The efficacy and safety of antiviral drugs of direct action in liver recipients with recurrence of chronic hepatitis C genotype 1 after transplantation

The efficacy and safety of antiviral drugs of direct action in liver recipients with recurrence of chronic hepatitis C genotype 1 after transplantation

Aim. To study the efficacy and safety of the use of paritaprevir, ritonavir, ombitasvir and dasabuvir in combination or without ribavirin in liver recipients with recurrence of HCV 1 genotype after transplantation.Materials and methods. The study included 46 patients after orthotopic liver transplan...

Full description

Saved in:
Bibliographic Details
Main Authors: О. M. Tsiroulnikova, D. V. Umrik, I. A. Miloserdov, Е. Т. Egorova, R. A. Latypov
Format: Article
Language:Russian
Published: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2019-01-01
Series:Вестник трансплантологии и искусственных органов
Subjects:
chronic hepatitis c
relapse
liver transplantation
direct antiviral action
3d­therapy
sustained virologic response
Online Access:https://journal.transpl.ru/vtio/article/view/951
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items